The present authors carried out an open-label pilot review that administered psilocybin to fifteen treatment-resistant tobacco/nicotine-dependent smokers, within the context of cognitive behavioral therapy for cigarette smoking cessation [58]. Individuals have been administered ~0.29 mg/kg oral psilocybin to the participant’s focus on day to Stop